Literature DB >> 23482526

Sapheon: the solution?

J Lawson1, S Gauw, C van Vlijmen, P Pronk, M Gaastra, M Mooij, C H A Wittens.   

Abstract

Less invasive endovenous techniques have been shown to be as effective as open surgery in the treatment of varicose veins. Furthermore, they cause less postoperative bruising and pain and enable early return to normal activities and work. Tumescent anaesthesia is safe and obviates complications of general or spinal anaesthesia. Drawbacks are a steep learning curve and painful administration during treatment. Tumescentless techniques like Clarivein™ or VenaSeal™ Sapheon Closure System are recently under investigation. Short-term results of VenaSeal™ are comparable with thermal ablation. The procedure is safe without serious adverse events. Perioperative pain and patient discomfort with this tumescentless approach is minimal but postoperative recovery is temporarily hindered by thrombophlebitis in 14-15 % of patients. One-year results in a small feasibility study has demonstrated durable closure at this endpoint. No longer-term results are available. A randomized control trial between VenaSeal™ and Covidien ClosureFast™ is in a preparatory phase.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23482526     DOI: 10.1177/0268355513475970

Source DB:  PubMed          Journal:  Phlebology        ISSN: 0268-3555            Impact factor:   1.740


  3 in total

Review 1.  Female Pelvic Vein Embolization: Indications, Techniques, and Outcomes.

Authors:  Anthony James Lopez
Journal:  Cardiovasc Intervent Radiol       Date:  2015-03-25       Impact factor: 2.740

2.  Persistent type IV hypersensitivity after cyanoacrylate closure of the great saphenous vein.

Authors:  Andrew D Jones; Edward M Boyle; Randy Woltjer; Jason P Jundt; Adam N Williams
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-08-07

3.  Stump Length Changes after Endovenous Cyanoacrylate Closure or Radiofrequency Ablation for Saphenous Vein Incompetence.

Authors:  Hyunmin Ko; Sangil Min; Sanghyun Ahn; Ahram Han; Jungsun Kim; Seung-Kee Min
Journal:  Vasc Specialist Int       Date:  2021-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.